Making Science Group, S.A.

MSE:MAKS.MC

9.1 (EUR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q22020 Q42020 Q2
Revenue 121.857113.909112.53197.60145.59834.44223.229
Cost of Revenue 102.755108.532105.71590.03239.86132.04921.77
Gross Profit 19.1025.3776.8177.5695.7372.3931.458
Gross Profit Ratio 0.1570.0470.0610.0780.1260.0690.063
Reseach & Development Expenses 0000000
General & Administrative Expenses 0000000
Selling & Marketing Expenses 0000000
SG&A 7.8587.4387.2657.5422.7991.507-0.04
Other Expenses 0.208-0.2140.1670.205-1.4240.344-0.228
Operating Expenses 7.657.6527.0987.3364.2231.1630.188
Operating Income 11.452-2.275-0.2810.2331.5141.231.27
Operating Income Ratio 0.094-0.02-0.0020.0020.0330.0360.055
Total Other Income Expenses Net -9.719-2.049-1.727-1.268-1.514-0.365-0.062
Income Before Tax 1.733-4.325-2.008-1.03500.8661.208
Income Before Tax Ratio 0.014-0.038-0.018-0.01100.0250.052
Income Tax Expense 1.0330.1991.350.16900.2730.259
Net Income 0.749-4.55-3.467-1.51800.5930.949
Net Income Ratio 0.006-0.04-0.031-0.01600.0170.041
EPS 0.09-0.55-0.42-0.1700.0860.14
EPS Diluted 0.09-0.55-0.42-0.1700.0860.14
EBITDA 11.9861.9833.8413.6961.5141.7451.639
EBITDA Ratio 0.0980.0170.0340.0380.0330.0510.071